Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

A 7-Gene Signature in Unmanipulated Leukaphereses Correlates with in-Vivo CAR T-Cell Expansion and Survival of Lymphoma Patients Receiving Tisagenlecleucel or Axicabtagene Ciloleucel Therapy

Cristiana Carniti, Nicole Caldarelli, Francesca Nanetti, Martina Magni, Emma Esposito, Tommaso Torelli, Luca Agnelli, Silvia Brich, Chiara Monfrini, Eugenio Fardella, Paolo Longoni, Daniele Lorenzini, Martina Pennisi, Annalisa Chiappella, Paolo Corradini

Blood (2022) 140 (Supplement 1): 641–643.

https://doi.org/10.1182/blood-2022-168796

Published: 2022

Journal Articles

Human CD34 + cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature

Cristiana Lavazza, Carmelo Carlo-Stella, Arianna Giacomini, Loredana Cleris, Marco Righi, Daniela Sia, Massimo Di Nicola, Michele Magni, Paolo Longoni, Marco Milanesi, Maura Francolini, Annunziata Gloghini, Antonino Carbone, Franca Formelli, Alessandro M. Gianni

Blood (2010) 115 (11): 2231–2240.

https://doi.org/10.1182/blood-2009-08-239632

Published: 2010

Includes: Supplemental data

Journal Articles

Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery

Anna Dodero, Cristiana Carniti, Anna Raganato, Antonio Vendramin, Lucia Farina, Francesco Spina, Carmelo Carlo-Stella, Simona Di Terlizzi, Marco Milanesi, Paolo Longoni, Lorenza Gandola, Claudia Lombardo, Paolo Corradini

Blood (2009) 113 (19): 4771–4779.

https://doi.org/10.1182/blood-2008-10-183723

Published: 2009

Includes: Supplemental data

Journal Articles

Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas

Carmelo Carlo-Stella, MD, Cristiana Lavazza, PhD, Arianna Giacomini, PhD, Loredana Cleris, Daniela Sia, PhD, Paolo Longoni, Marco Milanesi, Michele Magni, MD, Massimo Di Nicola, MD, Annunziata Gloghini, PhD, Antonino Carbone, MD, Marco Righi, MD, Franca Formelli, PhD, Alessandro M. Gianni, MD

Blood (2008) 112 (11): 2605.

https://doi.org/10.1182/blood.V112.11.2605.2605

Published: 2008

Journal Articles

CD8-Depleted Donor Lymphocyte Infusions Can Improve Both T- and B-Cell Reconstitution after Allogeneic Stem Cell Transplantation from Haploidentical Family Donors

Anna Dodero, MD, Cristiana Carniti, PhD, Anna Raganato, PhD, Antonio Vendramin, PhD, Simona Di Terlizzi, PhD, Lucia Farina, MD, Francesco Spina, MD, Franca Fossati Bellani, MD, Marco Milanesi, PhD, Paolo Longoni, PhD, Lorenza Gandola, MD, Claudia Lombardo, MD, Paolo Corradini, MD

Blood (2008) 112 (11): 354.

https://doi.org/10.1182/blood.V112.11.354.354

Published: 2008

Journal Articles

Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature.

Carmelo Carlo-Stella, MD, Cristiana Lavazza, Arianna Giacomini, Daniela Sia, Loredana Cleris, Massimo Di Nicola, M.D., Paolo Longoni, Marco Milanesi, Michele Magni, M.D., Marco Righi, M.D., Maura Francolini, Annunziata Gloghini, Anna Guidetti, M.D., Antonino Carbone, M.D., Alessandro M. Gianni, M.D.

Blood (2007) 110 (11): 527.

https://doi.org/10.1182/blood.V110.11.527.527

Published: 2007

Journal Articles

Antitumor Activity of Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (mTRAIL).

Carmelo Carlo-Stella, MD, Cristiana Lavazza, PhD, Massimo Di Nicola, MD, Loredana Cleris, Paolo Longoni, Marco Milanesi, Michele Magni, MD, Daniele Morelli, MD, Annunziata Gloghini, MD, Antonino Carbone, MD, Alessandro M. Gianni, MD

Blood (2006) 108 (11): 233.

https://doi.org/10.1182/blood.V108.11.233.233

Published: 2006

Journal Articles

CD8-Depleted Donor Lymphocyte Infusions Can Boost Immune Reconstitution after Haploidentical Stem Cell Transplantation Following Reduced-Intensity Conditioning Regimen.

Paolo Corradini, Anna Raganato, Cristiana Carniti, Matteo Carrabba, Farina Lucia, Vittorio Montefusco, Raffaella Milani, Marco Milanesi, Paolo Longoni, Elisabetta Zorzan, Lorenza Gandola, Claudia Lombardo, Anna Dodero

Blood (2006) 108 (11): 3138.

https://doi.org/10.1182/blood.V108.11.3138.3138

Published: 2006

Journal Articles

Interferon γ Enhances the Anti-Myeloma Activity of the Fully Human Anti-HLA-DR Monoclonal Antibody 1D09C3.

Carmelo Carlo-Stella, MD, Anna Guidetti, MD, Massimo Di Nicola, MD, Cristiana Lavazza, Loredana Cleris, Paolo Longoni, Marco Milanesi, Michele Magni, MD, Zoltan Nagy, Paolo Corradini, MD, Antonino Carbone, MD, Franca Formelli, Alessandro M. Gianni, MD

Blood (2006) 108 (11): 656.

https://doi.org/10.1182/blood.V108.11.656.656

Published: 2006

Journal Articles

Telomere Length of Hematopoietic Cells in Long-Term Post-Autograft Survivors: No Evidence of Accelerated Replicative Cell Senescence Despite the Persistent Reduction of Both Committed and Immature Progenitor Cell Compartments.

Alberto Rocci, MD, Irene Ricca, MD, Chiara Della Casa, MD, Paolo Longoni, PhD, Mara Compagno, PhD, Maurizio Battistelli, PhD, Roberto Francese, PhD, Federica De Marco, MD, Daniele Caracciolo, MD, Mario Boccadoro, MD, Dario Ferrero, MD, Marco Ladetto, MD, Carmelo Carlo-Stella, MD, Corrado Tarella, MD

Blood (2004) 104 (11): 4123.

https://doi.org/10.1182/blood.V104.11.4123.4123

Published: 2004

Journal Articles

In Vitro and In Vivo Anti-Lymphoma Activity of the Anti-HLA-DR Monoclonal Antibody 1D09C3.

Carmelo Carlo-Stella, MD, Massimo Di Nicola, MD, Caterina Turco, MD, Loredana Cleris, Cristiana Lavazza, PhD, Marco Milanesi, Paolo Longoni, Elisabetta Zorzan, PhD, Michele Magni, MD, Massimo Ammirante, PhD, Arturo Leone, MD, Franca Formelli, PhD, Alessandro M. Gianni, MD

Blood (2004) 104 (11): 3285.

https://doi.org/10.1182/blood.V104.11.3285.3285

Published: 2004

Journal Articles

Primary Plasma Cells Expressing CD52 Are Efficiently Targeted In Vivo by Alemtuzumab.

Carmelo Carlo-Stella, MD, Massimo Di Nicola, MD, Paolo Longoni, Loredana Cleris, Marco Milanesi, Cristiana Lavazza, PhD, Raffaella Milani, MD, Matteo Carrabba, MD, Franca Formelli, PhD, Alessandro M. Gianni, MD, Paolo Corradini, MD

Blood (2004) 104 (11): 3460.

https://doi.org/10.1182/blood.V104.11.3460.3460

Published: 2004

Journal Articles

Placental Growth Factor (PlGF) Synergizes with Granulocyte Colony-Stimulating Factor (G-CSF) for the Mobilization of Primitive and Committed Peripheral Blood Progenitor Cells (PBPCs) in Nonhuman Primates.

Carmelo Carlo-Stella, MD, Massimo Di Nicola, MD, Paolo Longoni, Raffaella Milani, MD, Marco Milanesi, Michele Magni, MD, Loredana Cleris, Franca Formelli, PhD, Virgilio Pace, DVM, Francesco Colotta, MD, Alessandro M. Gianni, MD

Blood (2004) 104 (11): 4994.

https://doi.org/10.1182/blood.V104.11.4994.4994

Published: 2004

Journal Articles

Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34 + cells in poor mobilizers

Carmelo Carlo-Stella, Massimo Di Nicola, Raffaella Milani, Anna Guidetti, Michele Magni, Marco Milanesi, Paolo Longoni, Paola Matteucci, Franca Formelli, Fernando Ravagnani, Paolo Corradini, Alessandro M. Gianni

Blood (2004) 103 (9): 3287–3295.

https://doi.org/10.1182/blood-2003-07-2428

Published: 2004

NARROW

A 7-Gene Signature in Unmanipulated Leukaphereses Correlates with in-Vivo CAR T-Cell Expansion and Survival of Lymphoma Patients Receiving Tisagenlecleucel or Axicabtagene Ciloleucel Therapy

Human CD34 + cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature

Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery

Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas

CD8-Depleted Donor Lymphocyte Infusions Can Improve Both T- and B-Cell Reconstitution after Allogeneic Stem Cell Transplantation from Haploidentical Family Donors

Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature.

Antitumor Activity of Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (mTRAIL).

CD8-Depleted Donor Lymphocyte Infusions Can Boost Immune Reconstitution after Haploidentical Stem Cell Transplantation Following Reduced-Intensity Conditioning Regimen.

Interferon γ Enhances the Anti-Myeloma Activity of the Fully Human Anti-HLA-DR Monoclonal Antibody 1D09C3.

Telomere Length of Hematopoietic Cells in Long-Term Post-Autograft Survivors: No Evidence of Accelerated Replicative Cell Senescence Despite the Persistent Reduction of Both Committed and Immature Progenitor Cell Compartments.

In Vitro and In Vivo Anti-Lymphoma Activity of the Anti-HLA-DR Monoclonal Antibody 1D09C3.

Primary Plasma Cells Expressing CD52 Are Efficiently Targeted In Vivo by Alemtuzumab.

Placental Growth Factor (PlGF) Synergizes with Granulocyte Colony-Stimulating Factor (G-CSF) for the Mobilization of Primitive and Committed Peripheral Blood Progenitor Cells (PBPCs) in Nonhuman Primates.

Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34 + cells in poor mobilizers

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only